Trials / Conditions / Tourette's Syndrome

Tourette's Syndrome

21 registered clinical trials studyying Tourette's Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome NCT06361004	Xuanwu Hospital, Beijing	N/A
Recruiting	Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620	Brain Inflammation Collaborative	—
Completed	Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome NCT04805385	China Medical University Hospital	N/A
Completed	Brain-Behavior Interactions in Tic Suppression NCT02205918	University of Minnesota	—
Completed	Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years NCT02102698	Emalex Biosciences Inc.	Phase 2
Withdrawn	Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome NCT02112253	The University of Western Australia	Phase 1 / Phase 2
Withdrawn	Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome NCT01475383	Pfizer	Phase 2
Completed	Psychosocial Intervention for Young Children With Chronic Tics NCT03042507	Weill Medical College of Cornell University	N/A
Completed	Subthalamic Stimulation in Tourette's Syndrome NCT02619084	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	Phase 2
Withdrawn	A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome NCT01133353	Bausch Health Americas, Inc.	Phase 2
Completed	Ecopipam Treatment of Tourette Syndrome NCT01244633	Psyadon Pharma	Phase 1 / Phase 2
Completed	Physiological Investigations of Movement Disorders NCT01019343	National Institute of Neurological Disorders and Stroke (NINDS)	N/A
Unknown	Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for NCT00965211	Shalvata Mental Health Center	N/A
Unknown	Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD NCT00152750	University Health Network, Toronto	Phase 4
Completed	Hypersensitivity in Tourette Syndrome NCT00368433	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder NCT00241176	NYU Langone Health	Phase 4
Terminated	Safety Study of Galantamine in Tic Disorders NCT00226824	Parkinson's Disease and Movement Disorders Center	Phase 4
Terminated	Aripiprazole in the Treatment of Tourette's Syndrome NCT00282139	University of Florida	N/A
Completed	Brain Activation in Vocal and Motor Tics NCT00026000	National Institute of Neurological Disorders and Stroke (NINDS)	—
Terminated	Brain Tissue Collection for Neuropathological Studies NCT00001260	National Institute of Mental Health (NIMH)	—
Completed	High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome NCT00139308	Groupe Hospitalier Pitie-Salpetriere	Phase 1